Effectiveness of pharmacist care for patients with reactive airways disease: A randomized controlled trial

JAMA

Volumn 288, Issue 13, 2002, Pages 1594-1602

  Weinberger, Morris ^a,b,c,f   Murray, Michael D ^a,c,d   Marrero, David G ^c   Brewer, Nancy ^a   Lykens, Michael ^c   Harris, Lisa E ^a,c   Seshadri, Roopa ^c   Caffrey, Helena ^c   Franklin Roesner, J ^c   Smith, Faye ^a   Jeffrey Newell, A ^e   Collins, Joyce C ^e   McDonald, Clement J ^c   Tierney, William M ^a,b,c  

^a REGENSTRIEF INSTITUTE   (United States)

^b RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PURDUE UNIVERSITY   (United States)

^e CVS Caremark   (United States)

^f IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIASTHMATIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLXANTHINE DERIVATIVE;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; EMERGENCY WARD; FEMALE; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SATISFACTION; PEAK EXPIRATORY FLOW; PHARMACEUTICAL CARE; PHARMACIST; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TELEPHONE;

EID: 0037009919     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.288.13.1594     Document Type: Article

References (55)

1. McFadden ER, Gilbert IA. Asthma. N Engl J Med. 1992;327:1928-1937.
2. Ferguson GT, Cherniack RM. Management of chronic obstructive pulmonary disease. N Engl J Med. 1993;328:1017-1022.
3. Murray MD, Stang P, Tierney WM. Health care use by inner-city patients with asthma. J Clin Epidemiol. 1997;50:167-174.
4. Stroupe KT, Gaskins D, Murray MD. Healthcare costs of inner-city patients with asthma. J Asthma. 1999;36:645-655.
5. Weiss KB, Sullivan SD. The economic costs of asthma: a review and conceptual model. Pharmacoeconomics. 1993;4:14-30.
6. Gourley DR, Gourley GA, Solomon DK, et al. Development, implementation, and evaluation of a multicenter pharmaceutical care outcomes study. J Am Pharm Assoc (Wash). 1998;38:567-573.
7. Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash). 1998;38:574-585.
8. Gourley GA, Portner TS, Gourley DR, et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash). 1998;38:586-597.
9. Donahue JG, Weiss ST, Livingston JM, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277:887-891.
10. Suissa S, Ernst P, Benayoun S, et al. Low-dose inhaled corticosteroids and the prevention of death from asthma. N Engl J Med. 2000;343:332-336.
11. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-543.
12. Strand LM, Cipolle RJ, Morley PC, Perrier DG. Levels of pharmaceutical care: a needs-based approach. Am J Hosp Pharm. 1991;48:547-550.
13. Carlson DK. Nurses remain at top of honesty and ethics poll [news release]. Washington, DC: Gallup Poll Organization. November 27, 2000. Available at: http://www.gallup.com/poll/releases/pr001127.asp. Accessed July 2001.
14. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care setting: evidence and recommendations for future research. Ann Pharmacother. 1999; 33:1336-1355.
15. Tett SE, Higgins GM, Armour CL. Impact of pharmacist interventions on medication management by the elderly: a review of the literature. Ann Pharmacother. 1993;27:80-85.
16. Kennie NR, Schuster BG, Einarson TR. Critical analysis of the pharmaceutical care research literature. Ann Pharmacother. 1998;32:17-26.
17. Hatoum HT, Akhras K. A 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists. Ann Pharmacother. 1993; 27:1106-1119.
18. Lipton HL, Bero LA, Bird JA, McPhee SJ. The impact of clinical pharmacists' consultations on physicians' geriatric drug prescribing: a randomized controlled trial. Med Care. 1992;30:646-658.
19. Lipton HL, Bird JA. The impact of clinical pharmacists' consultations on geriatric patients' compliance and medical care use: a randomized controlled trial. Gerontologist. 1994;34:307-315.
20. Latner AW. The top 200 drugs of 1999. Pharm Times. 2000;66:16-32.
21. Murray MD, Loos B, Tu W, et al. Work patterns of ambulatory care pharmacists with access to electronic guideline-based treatment suggestions. Am J Health Syst Pharm. 1999;56:225-232.
22. Erickson SR, Kirking DM, Sandusky M. Michigan Medicaid recipients' perceptions of medication counseling as required by OBRA '90. J Am Pharm Assoc (Wash). 1998;38:333-338.
23. McDonough RP, Rovers JP, Currie JD, Hagel H, Vallandingham J, Sobotka J. Obstacles to the implementation of pharmaceutical care in the community setting. J Am Pharm Assoc (Wash). 1998;38:87-95.
24. Berger BA, Grimley D. Pharmacists' readiness for rendering pharmaceutical care. J Am Pharm Assoc (Wash). 1997;NS37:535-542.
25. Cowen DL. Changing relationship between pharmacists and physicians. Am J Hosp Pharm. 1992;49: 2715-2721.
26. Weinberger M, Murray MD, Marrero DG, et al. A pharmaceutical care program for patients with reactive airways disease. Am J Health Syst Pharm. 2001; 58:791-796.
27. Weinberger M, Murray MD, Marrero DG, et al. Issues in conducting randomized trials of health services research interventions in practice settings: the case of retail pharmacies. Health Serv Res. 2002;37: 1067-1077.
28. Hetzel MR, Williams IP, Shakespeare RM. Can patients keep their own peak flow records reliably? Lancet. 1979;1:597-599.
29. Janson-Bjerklie S, Shnell S. Effect of peak flow information on patterns of self-care in adult asthma. Heart Lung. 1988;17:543-549.
30. Cowie RL, Revitt SG, Underwood MF, Field SK. The effect of a peak flow-based action plan in the prevention of exacerbations of asthma. Chest. 1997;112: 1534-1538.
31. Gibson PG, Wlodarczyk J, Hensley MJ, Murree-Allen K, Olson LG, Saltos N. Using quality-control analysis of peak expiratory flow recordings to guide therapy for asthma. Ann Intern Med. 1995;123:488-492.
32. Troyanov S, Ghezzo H, Cartier A, Malo J. Comparison of circadian variations using FEV1 and peak expiratory flow rates among normal and asthmatic subjects. Thorax. 1994;49:775-780.
33. Banner AS, Shah RS, Addington WW. Rapid prediction of need for hospitalization in acute asthma. JAMA. 1976;235:1337-1338.
34. Mitchell DM, Gildeh P, Dimond AH, Collins JV. Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation. Thorax. 1986;41:606-610.
35. Sachs AP, Koeter GH, Groenier KH, van der Waaij D, Schiphuis J, Meyboom-de Jong B. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice. Thorax. 1995;50:758-763.
36. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J, for the International COPD Study Group. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet. 1998; 351:773-780.
37. Nunn AJ, Gregg I. New regression equations for predicting peak expiratory flow in adults. BMJ. 1989; 298:1068-1070.
38. Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax. 1992;47:76-83.
39. Juniper E, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis. 1993;147:832-838.
40. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773-778.
41. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis. 1987;136:225-244.
42. Badgett RG, Tanaka DJ, Hunt DK, et al. The clinical evaluation for diagnosing obstructive airways disease in high-risk patients. Chest. 1994;106:1427-1431.
43. Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: is self-report the best available measure? Med Care. 1981;19:1061-1064.
44. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74.
45. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846-857.
46. McDonald CJ, Overhage JM, Tierney WM, et al. The Regenstrief Medical Record System: a quartercentury experience. Int J Med Inf. 1999;54:225-253.
47. Ware JE, Davies-Avery A, Stewart AL. The measurement and meaning of patient satisfaction. Health Med Care Serv Rev. 1978;1:3-15.
48. Ware J E, Snyder ML, Wright WR, Davies AR. Defining and measuring patient satisfaction with medical care. Eval Program Plann. 1983;6:247-263.
49. Tierney WM, Overhage JM, Murray MD, et al. Effects of computerized guidelines for outpatient management of ischemic heart disease and heart failure. J Gen Intern Med. 1999;14(suppl):125.
50. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289-300.
51. Holms S. A sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
52. Weinberger M, Tierney WM, Booher P, Katz BP. Can the provision of information to patients with osteoarthritis improve functional status: a randomized controlled trial. Arthritis Rheum. 1989;32:1577-1583.
53. Tsuyuki RT, Jeffrey JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-1155.
54. Murray MD, Stang P, Tierney WM. Health care utilization by inner-city patients with asthma. J Clin Epidemiol. 1997;50:167-174.
55. American College of Physicians-American Society of Internal Medicine. Pharmacist scope of practice. Ann Intern Med. 2002;136:79-85.